resistanceBio, Inc. — Form D

resistanceBio, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-31. The offering totals $12.8M, of which $12.8M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-01-31
• Form: D
• Accession: 0002010024-24-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $12.8M
• Amount sold: $12.8M
• Minimum investment: $1
• Investors: 44
• Date of first sale: 2024-01-29
• Security types: equity, debt
• Revenue range: Decline to Disclose
• SEC file number: 021-504031

Issuer

• Name: resistanceBio, Inc.
• CIK: 0002010024
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 980 O'BRIEN DR, MENLO PARK, CA, 94025
• Phone: 925-708-6165

Officers, directors & promoters (7)

More

• CIK 2010024 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search